Dr. Bruno Sangro talks about the latest progress of immunotherapy for hepatocellular carcinoma скачать в хорошем качестве

Dr. Bruno Sangro talks about the latest progress of immunotherapy for hepatocellular carcinoma

Editor's note: In recent years, emerging combined immunotherapy has made a breakthrough in the field of liver cancer, significantly prolonging the survival time of patients with advanced hepatocellular carcinoma (HCC). At the 56th Annual Meeting of the European Society for the Study of the Liver (EASL2021) and the International Conference on the Liver (TM) (ILC 2021) in 2021, Bruno Sangro, President of the International Association for Liver Cancer (ILCA) and Professor of the University of Navarre, Spain, was invited to give a keynote speech on the latest advances in this cutting-edge therapy at the "Jean-Pierre Benhamou Clinical State-of-the-Art". Hepatology Digest reporter had the honor to interview Professor Sangro and ask him to express his personal views on relevant hot issues.